Controversies in family planning: intrauterine device placement in solid organ transplant patients.

Abstract:

:With an ever-increasing number of reproductive-aged women undergoing solid organ transplant and fertility improving after transplant, knowledge of the safety and efficacy of various contraceptive methods is essential to guide patient selection. We present the case of a 22-year-old patient desiring an intrauterine device (IUD) for contraception with a history of liver transplant as a child. The Centers for Disease Control and Prevention (CDC) and American Society for Transplantation (AST) offer conflicting recommendations on the use of IUDs in transplant patients. We review the literature for recommendations on IUD use in this population. While the literature is limited, levonorgestrel (LNG) and copper (Cu) IUDs appear to be safe and effective in solid organ transplant patients, with no evidence of unintended pregnancies or complications compared to those without organ transplant. Ultimately, patient preference should be the primary consideration in contraceptive choice, including between LNG or Cu-IUD.

journal_name

Contraception

journal_title

Contraception

authors

Gordon C,Harken T

doi

10.1016/j.contraception.2019.05.012

subject

Has Abstract

pub_date

2019-09-01 00:00:00

pages

250-252

issue

3

eissn

0010-7824

issn

1879-0518

pii

S0010-7824(19)30175-1

journal_volume

100

pub_type

杂志文章,评审
  • The probability of side effects with ovral, norinyl 1/50 and norlestrin.

    abstract::This report provides specific information on the prevalence rates of the most common side effects during the first 3 cycles of use of 3 combination oral contraceptives (OCs) containing 50 mcg estrogen. The probabilities of a symptom occurring for the first time, or persisting once present, during the initial cycles of...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(79)90050-7

    authors: Berger GS,Edelman DA,Talwar PP

    更新日期:1979-11-01 00:00:00

  • Induction of menstruation by antiprogesterone ZK 98.299 in cycling bonnet monkeys.

    abstract::The antiprogestin ZK 98.299 (11 beta-(4-dimethylaminophenyl)-17 alpha-hydroxy-17 beta-(3-hydroxypropyl)-13 alpha-methyl-4,9-gonadien-3-one) was administered s.c. (30mg/day) to two groups of cycling bonnet monkeys. In Group I (n = 6), it was injected from day 16 to 18 and in Group II (n = 9) from day 21 to 23 of the cy...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(87)90077-1

    authors: Puri CP,Elger WG,Pongubala JM

    更新日期:1987-04-01 00:00:00

  • Medical conditions, pregnancy perspectives and contraceptive decision-making among young people: an exploratory, qualitative analysis.

    abstract:OBJECTIVE:To explore perspectives on family planning among young people who perceive they are infertile or will have difficulty carrying a pregnancy to term owing to medical conditions or procedures. METHODS:This exploratory analysis examined pregnancy plans and contraceptive behavior among 12 young adults with a diag...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.03.046

    authors: Gomez AM,Arteaga S,Ingraham N,Arcara J

    更新日期:2019-07-01 00:00:00

  • Fertility after discontinuation of contraception: a comprehensive review of the literature.

    abstract:BACKGROUND:Fear of adverse effects on subsequent fertility following reversible contraceptive use is an important concern for some women. STUDY DESIGN:We undertook a comprehensive and objective review of the literature for prospective studies reporting pregnancy rates in women following contraceptive cessation. One-ye...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2011.04.002

    authors: Mansour D,Gemzell-Danielsson K,Inki P,Jensen JT

    更新日期:2011-11-01 00:00:00

  • A comparative study of Neo Sampoon, Ortho Vaginal Tablets and Emko Vaginal Tablets in Accra, Ghana.

    abstract::Neo Sampoon is an effervescent contraceptive vaginal tablet manufactured in Japan that contains 60 mg of the spermicide menfegol. Ortho Vaginal Tablets (OVT) and Emko Vaginal Tablets (EVT), both containing 100 mg of the spermicide nonoxynol-9, were manufactured in the USA. The three products were compared in a randomi...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(85)90015-0

    authors: Lamptey P,Klufio C,Smith SC,Feldblum PJ

    更新日期:1985-11-01 00:00:00

  • Termination of early pregnancy (menstrual induction) with 16-phenoxy-omega-tetranor PGE2 methylsulfonylamide.

    abstract::The efficacy and side effects of a new synthetic compound, 16-phenoxy-W-17, 18, 19, 20-tetranor prostaglandin E2 methylsulfonylamide, for menstrual induction. The study was conducted in an outpatient clinic in 240 patients with a delay in menstruation of 6-14 days. In 206 patients (86%) the immunologic pregnancy tes...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(77)90049-x

    authors: Karim SM,Rao B,Ratnam SS,Prasad RN,Wong YM,Ilancheran A

    更新日期:1977-10-01 00:00:00

  • STS 557, a new orally active progestin with antiprogestational and contragestational properties in rabbits.

    abstract::STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4.9(10)-diene-3-one) is a potent progestin. This compound was 10 times as potent as the standard levonorgestrel as judged by the classic Clauberg-McPhail Assay. The antiprogestational response is significant when STS 557 treatment starts 2 days before progesterone ad...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(80)90140-7

    authors: Oettel M,Kurischko A

    更新日期:1980-01-01 00:00:00

  • Associations between immediate postpartum long-acting reversible contraception and short interpregnancy intervals.

    abstract:OBJECTIVE:We aimed to evaluate the rates of short interpregnancy interval pregnancies and deliveries among women who receive immediate postpartum LARC. STUDY DESIGN:We conducted a retrospective cohort study of all women who delivered at Montefiore Medical Center between January 2015 and June 2016 (N = 9561). In this c...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.08.016

    authors: Wu M,Eisenberg R,Negassa A,Levi E

    更新日期:2020-12-01 00:00:00

  • Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations.

    abstract::The evaluation of the study was of the impact of oral contraceptive (OC) use on activated protein C (APC-resistance). Eight hundred eighteen young fertile women were screened for a study designed to compare three different marketed OC preparations. The women could have used either other oral contraceptive preparations...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0010-7824(01)00253-0

    authors: Endrikat J,Noah M,Gerlinger C,Bannemerschult R,Junge W,Ruebig A,Schmidt W,Düsterberg B

    更新日期:2001-10-01 00:00:00

  • Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

    abstract::The relationship of depot-medroxyprogesterone acetate (D-MPA) use to risk of cervical carcinoma in situ was investigated using data from a large multi-national, hospital-based case-control study. To avoid possible detection bias from Pap smear screening, final analyses were restricted to a subset of cases with symptom...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究

    doi:10.1016/0010-7824(94)00007-j

    authors: Thomas DB,Ye Z,Ray RM

    更新日期:1995-01-01 00:00:00

  • The effect of depot-medroxyprogesterone acetate on the fetus and nursing infant: a review.

    abstract::Data from published studies of the quantity of medroxyprogesterone acetate and/or its metabolites in the milk of lactating women receiving Depo-Provera for contraception is extrapolated into the amount of drug ingested daily by a theoretically average infant. Comparisons are made with the results of similar studies in...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/0010-7824(81)90027-5

    authors: Schwallie PC

    更新日期:1981-04-01 00:00:00

  • Effect of dose on the pharmacokinetics of levonorgestrel in the rat during the rapid elimination phase following subcutaneous administration.

    abstract::Adult female rats were given a single, subcutaneous injection of 8, 16 or 32 micrograms of levonorgestrel (LNG). Blood samples were collected at various time intervals and serum concentrations of LNG were determined by radioimmunoassay. The patterns of temporal decline in LNG concentrations in the three dose groups in...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(84)90009-x

    authors: Naqvi RH,Mitra SB,Lindberg MC

    更新日期:1984-12-01 00:00:00

  • Release kinetics of 3-keto-desogestrel from contraceptive implants (Implanon) in dogs: comparison with in vitro data.

    abstract::Ethylene-vinyl acetate (EVA) polymeric contraceptive implants (Implanon) containing 3-keto-desogestrel have been prepared aiming at an in vitro initial release rate of 60 micrograms 3-keto-desogestrel/day. These implants are designed to have an intended life-time of 2 years. During a 3-year period, the release of thes...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(93)90093-m

    authors: Geelen JA,van der Wardt JT,Voortman G,Maassen GC,Eenink MJ

    更新日期:1993-02-01 00:00:00

  • Time-controlled injectable occlusion of the vas deferens.

    abstract::An injectable method of obtaining vas deferens occlusion is presented. The agent used is styrene maleic anhydride (SMA) with dimethyl sulphoxide as the solvent. The special feature of the approach is that after a period of time, spermatozoa passage is spontaneously reestablished. By varying the dose of SMA administere...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(90)90073-5

    authors: Guha SK,Anand S,Ansari S,Farooq A,Sharma DN

    更新日期:1990-03-01 00:00:00

  • Plasma lipoproteins and fatty acid composition after "minipill".

    abstract::A study of the effect of a low-dose oral contraceptive, Adepal (ethinyl estradiol and levonorgestrel, 30 and 150 micrograms on the 5th to 12th, 40 and 200 micrograms on the 13th to 28th, respectively) on the blood lipids, lipoproteins and fatty acid composition has been conducted on 13 young women before and after six...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(83)90038-0

    authors: Sassolas A,Lagarde M,Guichardant M,Quincy C,Dechavanne M

    更新日期:1983-10-01 00:00:00

  • Flowers of Hibiscus rosa-sinensis, a potential source of contragestative agent: II. Possible mode of action with reference to anti-implantation effect of the benzene extract.

    abstract::Benzene extractives of Hibiscus rosa-sinensis flowers, administered during day 1-4 of gestation, exerted anti-implantation effect without affecting the tubal transport of zygote. On day 4, normal number of blastocyst was present in the uterus but they did not implant. However, as studied by pontamine blue reaction, it...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(85)90021-6

    authors: Pal AK,Bhattacharya K,Kabir SN,Pakrashi A

    更新日期:1985-11-01 00:00:00

  • Music as an auxiliary analgesic during first trimester surgical abortion: a randomized controlled trial.

    abstract:BACKGROUND:Music has served as an auxiliary analgesic in perioperative settings. This study evaluates the impact of intraoperative music added to routine pain control measures during first trimester surgical abortion. STUDY DESIGN:We analyzed data from 101 women randomized to undergo abortion with routine pain control...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2011.11.017

    authors: Guerrero JM,Castaño PM,Schmidt EO,Rosario L,Westhoff CL

    更新日期:2012-08-01 00:00:00

  • Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices.

    abstract::First year results of a randomized study of 1509 users of the Copper T380Ag with a silver core or of an IUD releasing 20 mcg day of levonorgestrel are reported. The cumulative gross pregnancy rate for each device was 0.3 per 100 at one year, with more than 490 women having one year of use with each device. The levonor...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(84)90036-2

    authors: Sivin I,Alvarez F,Diaz J,Diaz S,el Mahgoub S,Coutinho E,Brache V,Diaz MM,Faundes A,Pavez M

    更新日期:1984-11-01 00:00:00

  • Combined hormonal contraception and bone health: a systematic review.

    abstract::This systematic review examined whether women who use combined hormonal contraception experience changes in risk of fracture or bone mineral density (BMD) that differ from nonusers. We identified 86 articles from PubMed and EMBASE (published 1966 to August 2005) that reported on fracture or BMD outcomes by use of comb...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2006.01.003

    authors: Martins SL,Curtis KM,Glasier AF

    更新日期:2006-05-01 00:00:00

  • Contraceptive failure in the United States.

    abstract::This review provides an update of previous estimates of first-year probabilities of contraceptive failure for all methods of contraception available in the United States. Estimates are provided of probabilities of failure during typical use (which includes both incorrect and inconsistent use) and during perfect use (c...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2011.01.021

    authors: Trussell J

    更新日期:2011-05-01 00:00:00

  • The effects of Implanon on lipid metabolism in comparison with Norplant.

    abstract::This open, randomized study was intended to assess the effects of the new single-rod contraceptive implant (Implanon) containing etonogestrel on lipid metabolism in Indonesian women, in comparison with the six-rod implant Norplant, containing levonorgestrel. The effects of both products were compared with a control gr...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验,收录出版

    doi:10.1016/s0010-7824(99)00099-2

    authors: Suherman SK,Affandi B,Korver T

    更新日期:1999-11-01 00:00:00

  • Use of Norplant implants in a New York City clinic population.

    abstract::Two-hundred-eight women attending family planning clinics in New York City who received the Norplant contraceptive system during the first sixteen months of Norplant implants insertions were evaluated. Within this clinic population, Norplant implants were a popular contraceptive choice and were removed from 64 of the ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(94)90096-5

    authors: Gerber S,Westhoff C,Lopez M,Gordon L

    更新日期:1994-06-01 00:00:00

  • Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant.

    abstract::Uniplant, a single Silastic implant containing nomegestrol acetate, provides contraceptive efficacy for one year. Uniplant use for one year was studied in 1,803 healthy women of reproductive age, enrolled from 10 centers in 9 countries, after informed consent. Implants were placed subdermally either in the upper arm o...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(95)00263-4

    authors: Coutinho EM,de Souza JC,Athayde C,Barbosa IC,Alvarez F,Brache V,Gu ZP,Emuveyan EE,Adekunle AO,Devoto L,Shaaban MM,Salem HT,Affandi B,de Acosta OM,Mati J,Ladipo OA

    更新日期:1996-02-01 00:00:00

  • Physical examination prior to initiating hormonal contraception: a systematic review.

    abstract:BACKGROUND:Provision of contraception is often linked with physical examination, including clinical breast examination (CBE) and pelvic examination. This review was conducted to evaluate the evidence regarding outcomes among women with and without physical examination prior to initiating hormonal contraceptives. STUDY...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2012.08.010

    authors: Tepper NK,Curtis KM,Steenland MW,Marchbanks PA

    更新日期:2013-05-01 00:00:00

  • Progestin-only pill use and pill switching during breastfeeding.

    abstract::The opinions of 20 international experts in reproductive endocrinology and family planning service delivery were solicited concerning contraceptive pill use during breastfeeding and, in particular, to determine whether the experts felt that breastfeeding women who use progestin-only pills (POPs) should be advised to s...

    journal_title:Contraception

    pub_type: 社论

    doi:10.1016/0010-7824(95)00076-m

    authors: Visness CM,Rivera R

    更新日期:1995-05-01 00:00:00

  • A comparison of contraceptive procurement pre- and post-benefit change.

    abstract:BACKGROUND:In 2002, the Kaiser Foundation Health Plan in California changed its coverage policy to include 100% universal coverage for the most effective forms of contraception and for emergency contraceptive pills (ECPs). This study sought to evaluate whether removing the cost of contraception as a potential barrier t...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2007.07.006

    authors: Postlethwaite D,Trussell J,Zoolakis A,Shabear R,Petitti D

    更新日期:2007-11-01 00:00:00

  • Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device.

    abstract::Patterns of bleeding and plasma concentrations of levonorgestrel, progesterone, estradiol, LH and FSH were studied in ten volunteers who had a levonorgestrel-releasing IUD inserted postmenstrually. The IUD was designed to release 12 microgram/day. All but two of the volunteers ovulated during treatment. The ovulatory ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(80)90127-4

    authors: Nilsson CG,Lähteenmäki P,Luukkainen T

    更新日期:1980-02-01 00:00:00

  • The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.

    abstract:BACKGROUND:Polycystic ovary syndrome (PCOS) is an endocrine disorder associated with metabolic dysfunction and changes in cardiovascular risk markers, and using oral contraceptives (OCs) may exert a further negative effect on these alterations in patients with PCOS. Thus, the primary objective of this study was to asse...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2011.12.011

    authors: Vieira CS,Martins WP,Fernandes JB,Soares GM,dos Reis RM,de Sá MF,Ferriani RA

    更新日期:2012-09-01 00:00:00

  • The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease.

    abstract:CONTEXT:Progestins delivered by a variety of routes have been demonstrated, in addition to their high contraceptive effect, to have substantial benefits in the treatment of various gynecological disorders, and the intrauterine route has particular efficacy in treating endometrial and myometrial disorders. It should be ...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2006.12.013

    authors: Fraser IS

    更新日期:2007-06-01 00:00:00

  • In vivo measurements of uterine cavities in 795 women of fertile age.

    abstract::The uterine sound length, the functional length of the cervix including the zone of internal cervical os and the fundus transversal were determined in 795 fertile women in vivo using a measuring device, the Cavimeter. The functional cavity length was calculated by subtracting the functional length of the cervix from t...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(84)80011-6

    authors: Kurz KH,Tadesse E,Haspels AA

    更新日期:1984-06-01 00:00:00